Accelr8 Technology Corp.

New president named at diagnostics firm, divestiture announced

Published in Health Business Week, June 18th, 2004

Accelr8 Technology Corp. (AXK) announced the appointment of David Howson as president, effective April 1, 2004.

Howson previously served as a consultant to the company.

The company also announced that it has signed a letter of intent to divest its software migration tools business. Management expects to close the transaction, with a $500,000 purchase price, by the end of its current fiscal year ending July 31, 2004.

The appointment and the divestiture mark Accelr8's complete transition away from software and into medical diagnostic platforms that feature the company's surface chemistry and instrumentation technologies. This...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2004-06-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry